1 July 2022 - The NHS has saved taxpayers £1.2 billion in just three years, while securing cutting-edge treatments for ...
16 November 2021 - VPAS is a voluntary agreement between the UK government and the Association of the British Pharmaceutical ...
14 February 2021 - The aim of this paper is to examine generic competition in the UK, with a special focus ...
24 June 2020 - The UK results show how challenging switching to a biosimilar can be, according to patient groups. ...
20 January 2020 - Improving access to fairly priced, quality-assured generics and biosimilars is essential to realizing the potential public ...
5 December 2019 - While there is no question that falling prices that come with competition are cause for optimism in ...
9 October 2019 - The UK health service has well over a decade’s experience of dealing with biosimilars, but the ...
17 July 2019 - The preliminary survey results showed that 52% of patients received a letter from hospital about switching to ...
5 June 2019 - The United Kingdom’s National Health Service (NHS) has published a new document for clinical and nonclinical ...
23 October 2018 - The NHS’s bid to improve patient outcomes and save money by switching costly biological drugs for ...
4 September 2018 - Global leader in biosimilars, Celltrion Healthcare announces support for the easing of initiation boundaries for biologics that ...
2 August 2018 - The UK’s national healthcare provider saved £324 million by switching its patients to “better value” biosimilar ...
24 July 2018 - Slow adoption is costly. ...
30 November 2017 - NHS England will issue guidance to GPs and commissioners to limit the prescribing of “low value” ...
9 November 2017 - NICE is linking with user experience agency Sigma to develop a new system to improve the ...